1e – 60-Day Crosswalk for Model Prescriber Inquiry Letter

Crosswalk for Model Prescriber Inquiry Letter
July 2021 Version
September 2021 Version
Title of document

Changed “sample” to “model”

Type of
Change
Rev

Reason for change

Burden
Change
No

Accuracy,
consistency with
regulatory language
at 42 CFR §
423.2267 with
respect to model vs.
standardized
documents
INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This pre-decisional,
privileged, and confidential information is for internal government use only, and must not be disseminated, distributed, or
copied to persons not authorized to receive the information. For Preliminary discussion only, pending review of all public
comments. Unauthorized disclosure may result in prosecution to the full extent of the law.